Ardent Health Partners, LLC
Price Action
Technical Summary
EMERGING TRENDArdent Health Partners, LLC is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is weak (RS Rating: 41), showing significant lag compared to the market leaders. Earnings contraction of 3% provides fundamental context to the price action. Investors should exercise caution due to high volatility (56% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $9.14 | +6.42% | ABOVE |
| 50 SMA | $9.53 | +2.12% | ABOVE |
| 100 SMA | $9.33 | +4.25% | ABOVE |
| 150 SMA | $9.15 | +6.38% | ABOVE |
| 200 SMA | $10.26 | -5.16% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ARDT in an uptrend right now?
ARDT has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is ARDT overbought or oversold?
ARDT's RSI (14) is 51. The stock is in neutral territory, neither overbought nor oversold.
Is ARDT outperforming the market?
ARDT has a Relative Strength (RS) Rating of 41 out of 99. ARDT is currently lagging the broader market.
Where is ARDT in its 52-week range?
ARDT is trading at $9.73, which is 63% of its 52-week high ($15.48) and 26% above its 52-week low ($7.71).
How volatile is ARDT?
ARDT has a Beta of 1.27 and 52-week volatility of 56%. It's more volatile than the S&P 500 - expect bigger swings.